We present a descriptive analysis utilizing pharmacy claims from a managed care population to quantify adherence, persistence, and switching patterns for patients initiating dabigatran.
Heidi C. Lew, PharmD
Advertisement
Articles by Heidi C. Lew, PharmD
Improving Patient Self-Management of Multiple Sclerosis Through a Disease Therapy Management Program
This study evaluated the effect of a multiple sclerosis disease therapy management program on medication adherence, therapy persistence, relapses, work productivity, and quality of life.
Advertisement
Latest Updated Articles
- Adherence, Persistence, and Switching Patterns of Dabigatran Etexilate
September 16th 2013
Advertisement
Advertisement
Trending on AJMC
1
CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes
2
ATTR-CM Incidence, Prevalence Rose Sharply in the US
3
FDA Approves Palbociclib for HR+, HER2+ Breast Cancer Maintenance
4
Mixed Phase 3 Results for IB6-Targeting ADC Raise Questions on Optimal Use in NSCLC
5